Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
New Strong Sell Stocks for August 2nd
10:42am, Monday, 02'nd Aug 2021
ATTO, BLDP, NTB, CCJ and EBS have been added to the Zacks Rank #5 (Strong Sell) List on August 2, 2021.
Emergent (EBS) Misses on Q2 Earnings, to Restart Bayview Unit
11:24am, Friday, 30'th Jul 2021
Emergent's (EBS) second-quarter 2021 earnings miss estimates. Revenues also fail to meet expectations.
U.S. authorities probing Emergent BioSolutions over COVID-19 vaccine issues -filing
10:18am, Friday, 30'th Jul 2021
Drug manufacturer Emergent BioSolutions Inc on Friday said it has received inquiries and subpoenas from a swathe of U.S. authorities related to its abilities to manufacture COVID-19 bulk drug substanc
Emergent Biosolutions' (EBS) CEO Bob Kramer on Q2 2021 Results - Earnings Call Transcript
10:39pm, Thursday, 29'th Jul 2021
Emergent Biosolutions' (EBS) CEO Bob Kramer on Q2 2021 Results - Earnings Call Transcript
Emergent Biosolutions (EBS) Lags Q2 Earnings and Revenue Estimates
08:31pm, Thursday, 29'th Jul 2021
Emergent Biosolutions (EBS) delivered earnings and revenue surprises of -81.77% and -4.39%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Emergent BioSolutions Stock Higher As COVID-19 Vaccine Production To Resume At Baltimore Plant
10:16am, Thursday, 29'th Jul 2021
Emergent BioSolutions Inc (NYSE: EBS) will resume production of Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine at its troubled Baltimore facility, where operations were stopped in April after m
Emergent BioSolutions to Resume Manufacturing Covid-19 Vaccine at Bayview Facility
07:25am, Thursday, 29'th Jul 2021
GAITHERSBURG, Md., July 29, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the U.S. Food and Drug Administration (FDA) is allowing Emergent's Bayview manufacturing
Reverse the Silence Campaign Casts a National Spotlight on Overdose Risks Associated with Opioid Use
09:01am, Monday, 26'th Jul 2021
GAITHERSBURG, Md., July 26, 2021 (GLOBE NEWSWIRE) -- An alliance of national nonprofit organizations comprised of Community Anti-Drug Coalitions of America (CADCA), Mothers Against Prescription Drug
These Companies Have Seen Large Returns From 2020 Government Investment
04:40pm, Friday, 23'rd Jul 2021
Much focus on investment comes from the private sector, particularly those of the venture capitalist persuasion. But one of the biggest investors this country has is the federal government.
Emergent BioSolutions to Release Second Quarter 2021 Financial Results and Conduct a Conference Call on July 29, 2021
06:30am, Thursday, 15'th Jul 2021
GAITHERSBURG, Md., July 15, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, July 29, 2021 at 5:00 pm eastern time to discuss the financial resu
Can Emergent BioSolutions Recover From Its Recent Blunders?
08:02am, Saturday, 03'rd Jul 2021
Yes, but it probably won't be an easy path.
Faruqi & Faruqi, LLP is Investigating Emergent BioSolutions (EBS) on Behalf of its Shareholders
09:06am, Wednesday, 23'rd Jun 2021
New York, New York--(Newsfile Corp. - June 23, 2021) - Faruqi & Faruqi, LLP, a leading minority and Woman-owned national securities law firm, is investigating potential misconduct at Emergent BioSolut
New York, New York--(Newsfile Corp. - June 21, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Em
New York, New York--(Newsfile Corp. - June 21, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between Ap
Los Angeles, California--(Newsfile Corp. - June 21, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Emergent BioSolution
